... Jun 11
These data further strengthen our confidence in Reblozyl’s potential to become a meaningful option for this important, underserved patient population around the world.â€... Jun 11
Molnupiravir, the antiviral drug was initially developed for the treatment of influenza and is repurposed to completely suppress the COVID virus transmission within 24 hours.... Jun 11
-Advertisements-